The Impact of Dialysate Magnesium on the Calcification Propensity of Serum
Not Applicable
Recruiting
- Conditions
- N18.5Chronic kidney disease, stage 5
- Registration Number
- DRKS00005230
- Lead Sponsor
- Abteilung für Nephrologie, Medizinische Klinik Bürgerspital Solothurn
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
chronic dialysis for more than 3 months
Exclusion Criteria
Gravidity
Age < 18y
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Calcification Propensity of serum determined by a new nephelometric test (precipitations Time T50) at 13 different time points in the study: Baseline (day 1 of week 1), T2 (day 1 of week 2), T3 (day 1 of week 3), T4 (day 2 of week 3), T5 (day 3 of week 3), T6 (day 1 of week 4), T7 (day 1 of week 5), T8 (day 1 of week 6), T9 (day 1 of week 7), T10 (day 2 of week 7), T11 (day 3 of week 7), T12 (day 1 of week 8) Baseline, T2 and T9-T12 with 0.5mmol Magnesium and T3-T8 with 0.75mmol<br>Of note: Day one, two or three corresponds to the first, second or third dialysis session in the corresponding week
- Secondary Outcome Measures
Name Time Method